What is Astra Nova?
Astra Nova Ltd is a UK-based entity specializing in comprehensive training solutions tailored for the Pharmaceutical and Clinical Research industries. The company offers a diverse portfolio of online and in-house courses, including critical areas such as Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and Good Distribution Practice (GDP). These programs are meticulously designed to align with stringent international regulatory requirements, serving clinical trial specialists and organizations of all scales. Astra Nova's mission is to bolster compliance and foster professional development within these highly regulated fields, with ambitions to build a global network of trainers delivering a wide array of topics to its clientele.
How much funding has Astra Nova raised?
Astra Nova has raised a total of $48.3M across 1 funding round:
Other Financing Round
$48.3M
Other Financing Round (2025): $48.3M, investors not publicly disclosed
What's next for Astra Nova?
The recent major strategic investment signals a new phase of growth and expansion for Astra Nova. This capital infusion is expected to fuel the company's strategic initiatives, potentially including the enhancement of its digital training platforms, expansion into new geographical markets, and the broadening of its course catalog to cover emerging trends in pharmaceutical and clinical research compliance. The company's focus on regulatory adherence positions it for sustained relevance and development in a dynamic global landscape.
See full Astra Nova company page
